In a report released today, Graham Doyle from UBS maintained a Buy rating on ConvaTec (CTEC – Research Report), with a price target of p345.00.

The surge in the anti-biofilm wound dressing market is largely attributed to the rising prevalence of acute and chronic wounds. As these conditions become more common, the need for innovative and ...

Wound Dressings Market The wound dressings market was valued at USD 10.1 billion in 2020 and is estimated to expand at a CAGR ...

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ConvaTec (CTEC) has stayed resolutely under the radar in recent years, despite building up a portfolio of products that has ultimately propelled it into the FTSE 100, following a successful IPO in ...

The wound healing process can be facilitated in two different ways, including traditional wound care (TWC) and advanced wound care (AWC). Chronic wounds take more time to heal and are expensive to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With the season of good cheer nearly upon us, investors seem to have missed out on surprises from unloved sectors ...